ICOS and gastric cancer: Nagase et al. demonstrated that the HP infection could upregulate the expression of TCR-inducible costimulatory receptor (ICOS) in pDC and Tregs, suggesting eradicating therapy for HP might serve as an indirect immune therapy for GC [75].